What is Boey, and how does its botulinum neurotoxin serotype E differ from other botulinum toxin products for treating g

What is Boey?

Boey (trenibotulinumtoxinE) is a botulinum neurotoxin serotype E that temporarily improves the appearance of moderate to severe glabellar lines – those vertical frown lines between the eyebrows that can make you look tired, angry, or worried – when those lines have an important psychological impact [10] [14]. It is the first and only rapid‑onset, short‑duration botulinum neurotoxin serotype E approved for this purpose, offering a different profile from the more familiar serotype A products (like BOTOX Cosmetic) [1] [6] [8].

How Boey’s serotype E differs from other botulinum toxin products

Molecular action

Most other botulinum toxins used for glabellar lines are serotype A. Although both serotypes attack the SNAP‑25 protein needed for nerve signals, they do so very differently:

• Serotype E (BoNT/E) cleaves SNAP‑25 more extensively, producing a faster and more potent blockade of neurotransmission [7].
• Serotype E also disrupts SNAP‑25 binding to syntaxin, making SNAP‑25 fall away, while serotype A leaves SNAP‑25 stuck to syntaxin [17].
• These molecular differences lead to significantly different potencies and paralytic patterns in neurons [16].

Speed of action

Boey can show noticeable results as early as eight hours after injection [2] [12] [19]. Classic serotype A neurotoxins normally require a couple of days before any change is visible, so Boey’s rapid onset is a key differentiator.

How long it lasts

The smoothing effect of Boey typically fades within two to three weeks [3] [12] [20]. That’s a short stint compared to the three to four months you might expect from serotype A products, giving people the flexibility to “try a toxin without the long‑term commitment” [4].

Clinical considerations

• In Phase 3 studies, Boey met all primary and secondary endpoints and confirmed onset as early as eight hours [22].
• BOTOX Cosmetic (onabotulinumtoxinA) is the only neurotoxin that has been clinically tested for use after Boey treatment [5] [21], which may matter for anyone planning to switch products.

Regulatory status (note on FDA)

The evidence provided shows Boey is approved in Canada [1] and received a positive CHMP opinion in Europe [11] [23]. No information about FDA approval is present in the given sources, so its status in the United States cannot be determined from this material.